How do vaccines work against cancer?
There are currently two specific cancers caused by viruses that can be prevented by vaccines, cervical cancer and liver cancer. The vaccines work by training our immune systems to fight off these viruses, which can otherwise stay in our bodies for a long time and can cause cancer later in life. Separately, there are also new vaccines starting to emerge that can be used to treat patients already with cancer. These teach a patient's immune system to detect and destroy cancer cells in their body.
One of the vaccines used to prevent cancer targets the human papillomavirus (HPV). This common virus can stay in the body a long time, damaging cells that can then grow out of control, leading to cancer. HPV can cause cervical, genital, anal and oral cancers.
The HPV vaccine is offered to all children aged 12-13 years old in the UK. By teaching your immune system to recognise HPV before you meet it, the vaccine can stop you getting infected. The HPV vaccine has been found to reduce cases of cervical cancer in women by 90% in those who received it at the age of 12 or 13 years.
Another vaccine that prevents cancer is the hepatitis B vaccine. The hepatitis B virus is the leading cause of liver cancer around the world and the hepatitis B vaccine prevents around 70% of hepatitis B-linked liver cancers.
There are currently three recently developed vaccines for treating people who already have cancer – known as therapeutic vaccines. These work against certain types of melanoma, prostate cancer and bladder cancer. Cancers are formed from malfunctioning cells in the body, meaning they are harder for our immune system to detect than invading microbes. But each type of cancer has a set of unique markers that can identify them, and therapeutic vaccines can be designed to teach our immune system to recognise these. While not licensed and therefore not widely available on the NHS yet, many of these vaccines are undergoing trials in the UK as part of the .
There are also ongoing attempts to develop more personalised therapeutic cancer vaccines that are specifically designed to target an individual patient’s cancer. These target specific markers produced by the genetic mutations found in a patient. The development of mRNA vaccines has led to significant developments in personalised therapeutic cancer vaccines.